Acute Myeloid Leukemia Clinical Trials in Dresden
4 recruitingDresden, Germany
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
Acute Myeloid Leukemia
Technische Universität Dresden214 enrolled21 locationsNCT04385290
Recruiting
Phase 2
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
AML (Acute Myeloid Leukemia)
Technische Universität Dresden60 enrolled1 locationNCT06696183
Recruiting
Phase 2
Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
Acute Myeloid Leukemia (AML)
University of Leipzig45 enrolled10 locationsNCT05833438
Recruiting
Phase 2
Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Acute Myeloid Leukemia
Technische Universität Dresden146 enrolled18 locationsNCT05904106